Home
Discovery Engines
Team
Portfolio
Offices
News
← View News
Jul 25, 2017
VenatoRx Pharmaceuticals Raises $42 Million Series B
Download PDF
Media Contact
Steve Edelson
(415) 801-8088
sedelson@versantventures.com